Goldman Sachs SELL::Healthcare Cipla Ltd. (Sell, on Conviction List) target price: Rs272, 4% potential downside

Please Share:: India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



Cipla: Premium to peers unwarranted
> Cipla’s premium valuation despite sub par revenue growth
> Margins continue to be under pressure as cycle of investment continue
> 12-mo TP is based on Director’s Cut